In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 2, p. 376-384
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 8, p. 2191-2200
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 12, p. 3624-3624
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 11, p. 3070-3078
|
In: Haematologica, 2020, vol. 105, no. 2, p. 448-456
BIRC3 is a recurrently mutated gene in chronic lymphocytic leukemia (CLL) but the functional implications of BIRC3 mutations are largely unexplored. Furthermore, little is known about the prognostic impact of BIRC3 mutations in CLL cohorts homogeneously treated with first-line fludarabine, cyclophosphamide, and rituximab (FCR). By immunoblotting analysis, we showed that the non-canonical...
|
In: Molecular and cellular biology, 2012, vol. 32, no. 21, p. 4432-4444
The transcription factor NF-κB regulates the expression of a broad number of genes central to immune and inflammatory responses. We identified a new molecular network that comprises specifically the NF-κB family member NF-κB1 (p50) and miR-146a, and we show that in mast cells it contributes to the regulation of cell homeostasis and survival, while in T lymphocytes it modulates T cell...
|
In: Journal of Experimental Neuroscience, 2018, vol. 12, p. -
Major depressive disorder (MDD) is one of the most common neuropsychiatric disorders affecting over one-fifth of the population worldwide. Owing to our limited understanding of the pathophysiology of MDD, the quest for finding novel antidepressant drug targets is severely impeded. Monoamine hypothesis of MDD provides a robust theoretical framework, forming the core of a large jigsaw puzzle, ...
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2009, vol. 28, no. 9, p. 1055-1065
|
In: European Journal of Pediatrics, 2008, vol. 167, no. 2, p. 141-148
|
In: Infection, 2008, vol. 36, no. 3, p. 274-278
|